Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Labcorp Q2 Revenue Rises 5.8 Percent to $3.73 Billion

None

Labcorp Holdings Inc. (LH) reported second-quarter 2026 revenue of $3.73 billion, up 5.8% from $3.53 billion a year earlier. Net earnings attributable to Labcorp were $298.7 million, compared with $237.9 million in the prior-year quarter, and diluted earnings per share were $3.64 versus $2.84.

The company raised its full-year 2026 enterprise revenue growth and adjusted EPS guidance, announced a $1.0 billion increase in its share repurchase authorization, and highlighted oncology, consumer health and technology initiatives.

  • Second-quarter revenue was $3.731 billion, with organic growth of 4.2%.
  • Basic EPS was $3.66 and diluted EPS was $3.64 for the quarter ended June 30, 2026.
  • Diagnostics Laboratories revenue rose 5.5% to $2.901 billion.
  • Biopharma Laboratory Services revenue rose 6.5% to $836.2 million.
  • Updated 2026 enterprise revenue guidance is $14.710 billion to $14.827 billion.
  • Labcorp repurchased $353.8 million of stock and paid $58.7 million in dividends during the quarter.

$LH Insider Trading Activity

LH Insider Trades

$LH insiders have traded $LH stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $LH stock by insiders over the last 6 months:

  • ADAM H SCHECHTER (President & CEO) has made 0 purchases and 3 sales selling 19,881 shares for an estimated $5,438,896.
  • PETER J WILKINSON (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 2,299 shares for an estimated $621,200.
  • BRIAN J CAVENEY (EVP, Pres of ED, CMO & CSO) sold 1,500 shares for an estimated $429,457
  • JONATHAN C MELTZER (EVP, Operations) has made 0 purchases and 4 sales selling 1,105 shares for an estimated $298,756.
  • KATHRYN W KYLE (EVP, Chief Legal Officer) has made 0 purchases and 2 sales selling 854 shares for an estimated $227,413.
  • DER VAART SANDRA D VAN (EVP, Corporate Affairs) sold 547 shares for an estimated $155,999
  • BRYAN T VAUGHN (EVP and President, Diagnostics) sold 234 shares for an estimated $66,968

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS
Receive LH Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$LH Hedge Fund Activity

We have seen 386 institutional investors add shares of $LH stock to their portfolio, and 463 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$LH Congressional Stock Trading

Members of Congress have traded $LH stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $LH stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles